The Cochrane Editorial Unit is pleased to announce the 10 successful titles from the second Cochrane Review Support Programme (CRSP) funding round.
- Delayed antibiotics for respiratory infections (Acute Respiratory Infections Group)
- Bisphosphonates and other bone agents for breast cancer (Breast Cancer Group)
- Psychological therapies for the treatment of mental disorders in low- and middle-income countries affected by humanitarian crises (Common Mental Disorders Group)
- Drug eluting stents versus bare metal stents for acute coronary syndrome (Heart Group)
- Withdrawal of antihypertensive drugs in older people (Hypertension Group)
- Pharmacotherapy for hypertension in adults aged 18 to 59 years (Hypertension Group)
- Interventions for preventing obesity in children (Public Health Group)
- Taxation of sugar-sweetened beverages for reducing their consumption and preventing obesity or other adverse health outcomes (Public Health Group)
- Interventions for treating depression after stroke (Stroke Group)
- Interventions to prevent occupational noise-induced hearing loss (Work Group)
We received 23 applications from 16 Groups. To evaluate the applications we convened an international assessment panel comprising nine Cochrane contributors and consumers of Cochrane Reviews, who generously shared their time and expertise:
Dr Urbà González, Unit of Dermatology, CLĺNICA GO&FER, Barcelona, Spain
Prof Sally Green, Australasian Cochrane Centre, Monash University, Melbourne, Australia
Dr Devan Kansagara MD, MCR, Associate Professor of Medicine, Oregon Health and Science University, Director, Evidence-based Synthesis Program, Portland VA Medical Center & Staff Physician, Portland VA Medical Center
Dr Richard Lehman, Hightown Surgery, Oxford, UK
Prof Ashraf F Nabhan, Department of Obstetrics and Gynaecology, Faculty of Medicine, Ain Shams University, Cairo, Egypt
Dr Mbah P Okwen, Centre for the Development of Best Practices in Health, Yaoundé Central Hospital, Yaoundé, Cameroon
Dr Sera Tort, Cochrane Editorial Unit, London, UK
Dr David Tovey, Editor in Chief, the Cochrane Library, Cochrane Editorial Unit, London, UK
Dr Jorge Zepeda, Secretary of Health of Florianópolis, Brazil / University of Leeds, UK
The panel members assessed the applications according to the criteria outlined in the application form and gave each review an overall score out of 10. The maximum possible score for each review was 90 (10 points x 9 assessors) and we set our funding cut-off at 60+.
The next funding round will open in September 2016 and will be advertised via the usual Cochrane communication channels.